NCT02979054View on ClinicalTrials.gov

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

NACompletedINTERVENTIONAL

Enrollment

157

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Keratoconus

Interventions

DEVICE

T4020

DEVICE

Placebo

Trial Locations (4)

63000

CHU, Clermont-Ferrand

Unknown

Hospital, Varna

Hospital, Vigo

Erciyes Üniversitesi Tıp Fakültesi, Kayseri

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY